Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly (LLY ... Over the last four quarters, Lilly surpassed consensus EPS estimates two times. The company topped consensus revenue estimates three times over this period. No investment decision ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Eli Lilly and Company (NYSE:LLY), a global pharmaceutical giant with a market capitalization of $700 billion, has been at the forefront of innovation in the biopharmaceutical industry ...

I recommend buying Eli Lilly and Company stock after strong Q2 ... (Technical Analysis) Aug. 12, 2024 9:37 AM ET Eli Lilly and ... We are not investment advisers and we never recommend stocks or ...

In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

Analyst Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target at $875.00. Mohit Bansal has given his Buy rating due to a ...

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right now, Lilly sells tirzepatide, commercialized as Mounjaro for type 2 ...

INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance, with Lilly’s ...